O. Paoletti

发表

External validation of the DASH prediction rule: a retrospective cohort study

W. Ageno, F. Dentali, A. Tosetto, 2017, Journal of thrombosis and haemostasis : JTH.

Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry

W. Ageno, E. Grandone, F. Violi, 2019, Journal of the American Heart Association.

Low drug levels and thrombotic complications in high‐risk atrial fibrillation patients treated with direct oral anticoagulants

R. Testa, S. Testa, D. Poli, 2018, Journal of thrombosis and haemostasis : JTH.

Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: Results observed in four anticoagulation clinics.

R. Abbate, S. Testa, D. Poli, 2016, Thrombosis research.

Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients

S. Testa, O. Paoletti, A. Pan, 2020, Internal and Emergency Medicine.

Direct oral anticoagulant plasma levels’ striking increase in severe COVID‐19 respiratory syndrome patients treated with antiviral agents: The Cremona experience

P. Prandoni, S. Testa, O. Paoletti, 2020, Journal of Thrombosis and Haemostasis.

Dabigatran but not rivaroxaban or apixaban treatment decreases fibrinolytic resistance in patients with atrial fibrillation.

S. Testa, O. Paoletti, C. T. Ammollo, 2016, Thrombosis research.

Effects of Oxytocin and Carbetocin on Haemostatic Variables in Pregnant Women after Cesarean Section

S. Testa, O. Paoletti, F. Catalano, 2015 .

Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago

W. Ageno, M. Moia, A. Tosetto, 2017, Internal and Emergency Medicine.

Bleeding and stroke risk in a real-world prospective primary prevention cohort of patients with atrial fibrillation.

G. Lip, S. Testa, D. Poli, 2011, Chest.

COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence.

S. Testa, O. Paoletti, A. Coppola, 2020, Blood transfusion = Trasfusione del sangue.

The “Pregnancy Health-care Program” for the prevention of venous thromboembolism in pregnancy

S. Testa, I. Martinelli, O. Paoletti, 2015, Internal and Emergency Medicine.

The Role of Anticoagulation Clinics in the Era of New Oral Anticoagulants

S. Testa, O. Paoletti, L. Bassi, 2012, Thrombosis.

Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants

R. Testa, S. Testa, D. Poli, 2019, Journal of thrombosis and haemostasis : JTH.

D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study

W. Ageno, P. Prandoni, N. Magrini, 2019, Internal and Emergency Medicine.

Pharmacogenetics of dabigatran etexilate interindividual variability.

G. Tiscia, M. Margaglione, E. Grandone, 2016, Thrombosis research.

Edoxaban plasma levels in patients with non-valvular atrial fibrillation: Inter and intra-individual variability, correlation with coagulation screening test and renal function.

S. Testa, O. Paoletti, C. Legnani, 2019, Thrombosis research.

Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study

R. Abbate, S. Testa, D. Poli, 2016, Journal of thrombosis and haemostasis : JTH.

Impact of a commercially available DOAC absorbent on two integrated procedures for lupus anticoagulant detection.

S. Testa, O. Paoletti, F. Peyvandi, 2021, Thrombosis research.

Thrombophilia testing in the real-world clinical setting of thrombosis centres taking part in the Italian Start 2-Register.

W. Ageno, E. Grandone, S. Testa, 2021, Blood transfusion = Trasfusione del sangue.

ABCB1 SNP rs4148738 modulation of apixaban interindividual variability.

G. Tiscia, M. Margaglione, N. Brunetti, 2016, Thrombosis research.

Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START‐Laboratory Register

S. Testa, D. Poli, B. Cosmi, 2018, International journal of laboratory hematology.

Dabigatran Plasma Measurement to Guide the Management of Acute Bleeding and Thrombotic Complications

S. Testa, O. Paoletti, M. Sessa, 2018, European journal of case reports in internal medicine.

Obstetrical history of women with cerebral vein thrombosis: outcome of the pregnancies before and after the thrombotic event

S. Testa, D. Poli, O. Paoletti, 2017, Internal and Emergency Medicine.

A global quality control system to check PT‐INR portable monitor for Antivitamin K antagonists

S Testa, O Paoletti, L Bassi, 2015, International journal of laboratory hematology.

Prevalence of asymptomatic deep vein thrombosis in patients hospitalized with SARS-CoV-2 pneumonia: a cross-sectional study

S. Testa, O. Paoletti, A. Pan, 2020, Internal and Emergency Medicine.

VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients

S. Calza, S. Testa, O. Paoletti, 2016, Medicine.

D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study

W. Ageno, P. Prandoni, E. Grandone, 2022, Blood advances.

The effect of management models on thromboembolic and bleeding rates in anticoagulated patients: an ecological study

A. Tosetto, S. Testa, I. Nichele, 2019, Internal and Emergency Medicine.

Telemedicine For Managing Patients on Oral Anticoagulant Therapy

S. Testa, O. Paoletti, L. Bassi, 2011 .

Reorganisation of an anticoagulation clinic using a telemedicine system: description of the model and preliminary results

S. Testa, O. Paoletti, Adriano Alatri, 2006, Internal and emergency medicine.

Differential effect of direct oral anticoagulants on thrombin generation and fibrinolysis in patients with atrial fibrillation and venous thromboembolism.

S. Testa, O. Paoletti, C. T. Ammollo, 2021, Blood transfusion = Trasfusione del sangue.

Comparison between different D‐Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study

A. Tosetto, S. Testa, D. Poli, 2016, International journal of laboratory hematology.

Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

J. Esser, G. Tiscia, M. N. D. Minno, 2012, Journal of thrombosis and haemostasis : JTH.

Treatment with argatroban in one haemodialysed patient with a heparin-induced thrombocytopenia and thrombotic complications

S. Testa, O. Paoletti, A. Alatri, 2010, Internal and emergency medicine.

ABCB1 SNP rs4148738 modulation of apixaban interindividual variability.

G. Tiscia, M. Margaglione, N. Brunetti, 2016, Thrombosis research.

Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes

W. Ageno, M. Di Nisio, L. Carrozzi, 2023, Research and Practice in Thrombosis and Haemostasis.